» Articles » PMID: 23657400

Macrophages Promote Tumour Growth and Liver Metastasis in an Orthotopic Syngeneic Mouse Model of Colon Cancer

Overview
Date 2013 May 10
PMID 23657400
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Tumour-associated macrophages have been shown to promote proliferation, angiogenesis and metastasis in several carcinomas. The effect on colon cancer has not yet been clarified. Furthermore, Kupffer cells in the liver might initiate the formation of metastases by directly binding tumour cells.

Methods: An orthotopic syngeneic mouse model of colon cancer as well as a liver metastases model has been studied, using murine CT-26 colon cancer cells in Balb/c-mice. Macrophages were depleted in both models by clodronate liposomes. Tumour sizes and metastases were determined using 7-Tesla MRI. The macrophage and vascular density in the orthotopic tumours as well as the Kupffer cell density in the livers were evaluated using immunohistochemistry.

Results: Animals in the macrophage-depleted group displayed significantly smaller primary tumours (37 ± 20 mm(3)) compared to the control group (683 ± 389 mm(3), p = 0.0072). None of the mice in the depleted group showed liver or peritoneal metastases, whereas four of six control mice displayed liver and five out of six mice peritoneal metastases. The vascular density was significantly lower in the macrophage-depleted group (p = 0.0043). In the liver metastases model, animals of the Kupffer cell-depleted group (14.3 ± 7.7) showed significantly less liver metastases than mice of the two control groups (PBS liposomes, 118.5 ± 28.2, p = 0.0117; NaCl, 81.7 ± 23.2, p = 0.0266). The number of liver metastases correlated directly with the Kupffer cell density (p = 0.0221).

Conclusion: Macrophages promote tumour growth, angiogenesis and metastases in this orthotopic syngeneic mouse model. Kupffer cells enhance the formation of metastases in the liver.

Citing Articles

The role of macrophages in liver metastasis: mechanisms and therapeutic prospects.

Yuan Q, Jia L, Yang J, Li W Front Immunol. 2025; 16:1542197.

PMID: 40034694 PMC: 11872939. DOI: 10.3389/fimmu.2025.1542197.


Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis.

Li S, Hao L, Hu X J Inflamm Res. 2024; 17:8429-8443.

PMID: 39529996 PMC: 11552512. DOI: 10.2147/JIR.S493656.


Role of Gut Microbiota in Predisposition to Colon Cancer: A Narrative Review.

Kamath H, Shukla R, Shah U, Patel S, Das S, Chordia A Indian J Microbiol. 2024; 64(3):1-13.

PMID: 39282181 PMC: 11399513. DOI: 10.1007/s12088-024-01242-5.


Orthotopic and metastatic tumour models in preclinical cancer research.

Stribbling S, Beach C, Ryan A Pharmacol Ther. 2024; 257:108631.

PMID: 38467308 PMC: 11781865. DOI: 10.1016/j.pharmthera.2024.108631.


Lipid Nanoparticles-Based Therapy in Liver Metastasis Management: From Tumor Cell-Directed Strategy to Liver Microenvironment-Directed Strategy.

Wang Y, Yin Z, Gao L, Ma B, Shi J, Chen H Int J Nanomedicine. 2023; 18:2939-2954.

PMID: 37288351 PMC: 10243353. DOI: 10.2147/IJN.S402821.


References
1.
Khatib A, Fallavollita L, Wancewicz E, Monia B, Brodt P . Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res. 2002; 62(19):5393-8. View

2.
Bailey C, Negus R, Morris A, Ziprin P, Goldin R, Allavena P . Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis. 2007; 24(2):121-30. DOI: 10.1007/s10585-007-9060-3. View

3.
Van Ginderachter J, Movahedi K, Hassanzadeh Ghassabeh G, Meerschaut S, Beschin A, Raes G . Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology. 2006; 211(6-8):487-501. DOI: 10.1016/j.imbio.2006.06.002. View

4.
Renehan A, Egger M, Saunders M, ODwyer S . Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002; 324(7341):813. PMC: 100789. DOI: 10.1136/bmj.324.7341.813. View

5.
Luo Y, Zhou H, Krueger J, Kaplan C, Lee S, Dolman C . Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest. 2006; 116(8):2132-2141. PMC: 1513049. DOI: 10.1172/JCI27648. View